CLINICAL_TRIALS
trial_result
· 2017-10-19
Clinical Trial Update: Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Summary
A completed clinical trial evaluated the impact of Xenazine (tetrabenazine) on gait and functional activity in individuals with Huntington's disease; results we…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ohio State University | Conditions: Huntington's Disease | Status: COMPLETED | Results posted: 2017-10-19